Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
193.47
-0.15 (-0.08%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about AbbVie
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
60
61
Next >
AbbVie's Recent ImmunoGen Acquisition Looks Brilliant: Here's Why
December 26, 2023
The acquisition fills an immediate need with some extras to boot.
Via
The Motley Fool
29 Undervalued Dividend Aristocrats: December 2023
December 25, 2023
The S&P 500 Dividend Aristocrats Index contains 67 dividend growth stocks called the Dividend Aristocrats.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Market Whales and Their Recent Bets on ABBV Options
December 22, 2023
Via
Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $300 Today
December 21, 2023
Via
Benzinga
Better Growth Stock: AbbVie vs. Abbott Laboratories
December 21, 2023
Do Humira's declining sales give Abbott Laboratories the edge as the better growth stock?
Via
The Motley Fool
7 Blue-Chip Dividend Stocks to Buy Before Dec. 31
December 19, 2023
Always a strong investment, blue-chip dividend stocks continue to make sense as 2023 draws closer to an end and 2024 nears.
Via
InvestorPlace
8 Analysts Have This to Say About AbbVie
December 18, 2023
Via
Benzinga
Better Income Stock: AT&T or AbbVie?
December 17, 2023
These two blue chips are highly prized for their top-shelf dividend programs.
Via
The Motley Fool
Decoding AbbVie's Options Activity: What's the Big Picture?
December 14, 2023
Via
Benzinga
7 ‘Bulletproof’ Stocks to Buy Ahead of a Wild New Year
December 19, 2023
If you don’t quite trust the hyper-bullish narrative, these ideas can help boost confidence.
Via
InvestorPlace
Stock(ing) Stuffers That Could Be Lovin The High 2024
December 18, 2023
Via
Talk Markets
Healthcare Sector Stocks: Consistent Above-Average Growth And Income
December 18, 2023
The healthcare sector is full of many really good companies with consistent, long term, above-average growth rates and many that have good, consistent, long-term dividend records.
Via
Talk Markets
3 of the Most Attractive Dividend Stocks in the Pharma Space
December 17, 2023
Discover the resilience and growth potential of pharma dividend stocks, offering stability and consistency in the healthcare sphere.
Via
InvestorPlace
Dividend Income Update For November 2023
December 16, 2023
It’s dividend income update time. This is one of my favorite times of the month, as I get to review the previous month of passive income received from my dividend income portfolio.
Via
Talk Markets
$100 Invested In AbbVie 10 Years Ago Would Be Worth This Much Today
December 13, 2023
Via
Benzinga
3 Fantastic Stocks That Could Enjoy a Santa Claus Rally
December 16, 2023
These stocks could bring investors more than just a lump of coal for Christmas.
Via
The Motley Fool
Exposures
Coal
10 Health Care Stocks Whale Activity In Today's Session
December 14, 2023
Via
Benzinga
The 7 Most Undervalued Growth Stocks to Buy in December
December 13, 2023
Buy these distressed names now and ride their share prices higher over the coming year as they stage a comeback.
Via
InvestorPlace
Economic Safety Nets: 7 Defensive Stocks Providing Portfolio Stability
December 13, 2023
Although some signs of economic progress is seen, other signs suggest that investors should consider defensive stock picks.
Via
InvestorPlace
Botox And Similar Injections Have Associated Risks: Consumer Group Pushes for Stronger Warnings
December 12, 2023
Consumer advocacy group Public Citizen has filed a petition with the FDA, urging the agency to demand stronger warnings regarding the risk of a potentially fatal muscle-paralyzing disease linked to...
Via
Benzinga
Exposures
Product Safety
AbbVie Just Followed Pfizer's Big Move. Here's What It Means For Investors
December 12, 2023
It's making a major acquisition to beef up a key area of its pipeline.
Via
The Motley Fool
Bristol Myers Squibb Further Diversifies Oncology Portfolio With Mega $8.4B Deal
December 12, 2023
SystImmune and Bristol Myers Squibb & Co (NYSE: BMY)
Via
Benzinga
Biotech Is Coming Back, Can The Run Last?
December 11, 2023
The rally can be attributed to lower interest rates and seasonal factors from the end of Q4 through January. But recently some major biopharmaceutical deals have supported the rally.
Via
Talk Markets
The 3 Best Cheap Stocks to Buy in December
December 10, 2023
Investors wanting to buy low and sell high should consider a position in one of these great companies whose shares have pulled back lately.
Via
InvestorPlace
4 Top Dividend Stocks Yielding More Than 4% to Buy Hand-Over-Fist This December
December 10, 2023
These companies offer above-average income streams that should continue rising.
Via
The Motley Fool
AbbVie Just Announced 2 Big Acquisitions: Is This Dividend King a No-Brainer Buy Right Now?
December 10, 2023
The big drugmaker went on a holiday shopping spree.
Via
The Motley Fool
3 Dividend Stocks You Can Safely Hold for Decades
December 09, 2023
These companies and their dividends are built to last.
Via
The Motley Fool
Better Dividend Stock: AbbVie vs. Medical Properties Trust
December 09, 2023
Which of these high-yield stocks has what it takes to keep raising their payouts?
Via
The Motley Fool
3 High-Yielding Dividend Stocks That Are Near Their 52-Week Lows
December 08, 2023
Buying these shares can provide you with some excellent recurring income while also diversifying your portfolio.
Via
The Motley Fool
AbbVie's on an Acquisition Binge. Could Your Favorite Biotech Stock Be Next?
December 08, 2023
Here's what's attracting lucrative buyout offers from big pharmaceutical companies these days.
Via
The Motley Fool
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
60
61
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.